28 6 Voice Bridges Project 1 2 3 2 1 29 3 30 12 11 209 1 45.3 76.1% 47.4% 67.5% 95.2% DAST-20 11.2 76.6% 1 78.3% 73.9% 4 13.0% 8.7% - 15 -
1 1 1 22.1% 52.9% 2 Voice Bridges Project,, - 16 -
- 17 -
. 27 11 1) 28 6-18 -
Voice Bridges Project VBP: 29 3 VBP VBP VBP. 1 2 2 1 a. 1 3 1 3 4 2 3 2 9 2 1 6 2 3 1 29 3 1 30 12 2-19 -
3 29 3 30 12 11 8 29 3 29 12 23 30 4 30 6 30 7 4 3 2 ID ID 5 1 1 DAST-20 3 QOL 2 QOL 6-20 -
29 7 1 QOL 1 t 2 2 t 29 8 b. 1 1 2 29 3 30 12 273 209 76.6% 164 78.5% 3 52 2 209 3 9 45.3 10.1 159 76.1% 50 23.9% 130 62.2% (51 24.4%) 11 5.3% 110-21 -
52.6% 53 25.4%41 19.6% 4 85 40.7% 98 46.9% 114 54.5% 90 43.1% 51 24.4% 18 8.6% 141 67.5% 15 7.2% 35 16.7% 53 25.4% 4 5 88 42.1% C 25 12.0% HIV 6 2.9% 64 30.6% 51 24.4% 67 32.1% 41 19.6% 26 12.4% 6 2.9% 199 95.2% 4 1.9% 2 1.0% 1 0.5% 1 0.5% 1 0.5% 1 0.5% 19.7 7.3 160 76.6% 139 17 13 13 8 6 8 QOL 39 18.7% 170 81.3% 106 (60 ) 51 47 46 137 65.6% 68 (63 ) 61 51 40 QOL 7 3.3% 35 16.7% 86 41.1% 45 21.5% 33 15.8% 23 11.0% 62 29.7% 47 22.5% 58 27.8% 16 7.7% 9 DAST-20 3 11.2 4.2 Low 0-5 23 8.5% Intermediate 6-10 60 22.0% Substantial 11-15 95 34.8% Severe 16-20 31 11.4% 3 10 2018 12 73.2 87. 7% 1 8 209 1-22 -
12.9% 1 8 11 3 135 8 5.9% 6 78 8 10.3% 9 52 3 13.0% 1 23 3 13.0% 1 5 5 100.0% 1 1 100.0% 1 540 95% 377.7-702.3 4 1 12 16 1 23 1 QOL 39.4 12.5 45.3 4 47.8% 56.5% 4 4.3% 17.4% 47.8% 21.7% 21.7% 39.1% 17.4% 26.1% 13.0% 26.1% 0.0% 8.7% 1 43.5% 91.3% 7 1 78.3% 73.9% 39.1% 65.2% 13.0% 0.0% 8.7% 8 1 26.1% 4.3% 39.1% 8.7% 0.0% 8.7% 30.4% 43.5% 1 26.1% 17.4%21.7% 0.0% 2 QOL 2 5 17 2 1018 225 22.1% 2018 12 209 225 16 45.7 10.0 43.4 10.5 p=0.003 225175 77.8% 293 247 84.3% 2 p=0.35-23 -
2 p=0.012 66.7% 70.4% 21.8% 13.9% 8 8.4% 13.2% 3.1% 2.5% 24.9% 16.4 2 p=0.006 52.9% 62.8% 44.0% 29.4% 18 29 29 97.5% 1.8% 0.6% 92.8% 6.7% c. 1 1 29 3 2 4 11 2 7~8 1 1 1 2 75% 45 55% 2) 95% - 24 -
53% 5 2 7 QOL 1~5 3 QOL 8 3 7 7% 3% 7% 3 1 3-25 -
135 8 5.8% 1 23 3 13.0% 1 5 5 100.0% 1 1 1 6 540 95% 377.7-702.3 1 95% 3 Cox 4 1 1 8 2 7 1 9 QOL 8 7 4 65% 13% - 26 -
2 a. VBP VBP 2 i) ii) iii) iv) v) VBP vi) vii) VBP viii) ix) x) xi) xii) 2-27 -
3 3 5 VBP b. 1 ( 29 8 ) 156 26 15 VBP 2 30 1 29 7 1-28 -
2 ( 29 9 ) 29 8 1 1,502,599 2 28 1,005 440 84 SMARPP DA GA 3 1 3 ( 30 2 ) 2 1-29 -
SMARPP 5 1 4 30 7 30 421 7 112 67 TAMARPP 3 TAMARPP 27 7 TAMARPP 29 TAMARPP - 30 -
TAMARPP 6 NA TAMARPP 1 TAMARPP TAMARPP TAMARPP VBP TAMARPP TAMARPP TAMARPP 5 ( 30 12 ) 23 284 119 22 30 JR 20 VBP 12 22 SMARPP SMARPP 24 1 25 SMARPP 25 27 VBP - 31 -
VBP VBP c. 2 1 1 2-32 -
VBP 3. - 33 -
5 1 2 3 1 4 5 2 1 Voice Bridges Project Voice Bridges Project 1-34 -
Voice Bridges Project 1 SMARPP 18. 29 3 Voice Bridges Project 11-35 -
1. 1) Takano A, Miyamoto Y, Kawakami N, Matsumoto T: Web-Based cognitive behavioral relapse prevention program with tailored feedback for people with methamphetamine and other drug use problems: Development and Usability Study. JMIR Mental Health 3: 1-17, 2016. 2) Okumura Y, Shimizu S, Matsumoto T: Prevalence, prescribed quantities, and trajectory of multipleprescriber episodes for benzodiazepines: A 2-year cohort study. Drug and Alcohol Dependence 158:118-25, 2016. 3) Matsumoto T, Tachimori H, Takano A, Tanibuchi Y, Funada D, Wada K: Recent changes in the clinical features of patients with new psychoactivesubstances-related disorders in Japan: Comparison of the Nationwide Mental Hospital Surveys on Drug-related Psychiatric Disorders undertaken in 2012 and 2014. Psychiatry and Clinical Neurosciences, 70: 560 566, 2016. 4) : STEM 51(1) 26-37 2016 5) : SMARPP 1 51(1) 38-54 2016 6) DARC SMARPP 51 6 414-424 2016 7) : 51(5) 335-347 2016 8) 26 11-24 2017 9) : 1. 52(1): 34-55, 2017. 10) - 36 -
52 5 141-155 2017. 11) : 4808 19-23 2016 12) : SMARPP 42(4) 571-579 2016 13) : 19(8) 1125-1136 2016 14) : SMARPP 18(1) 123-125 2016 15) : 31(11) 1449-1454 11 2016 16) : 68(11) 10-11 2016 17) : 31(11) 1449-1454 11 2016 18),, : Voice Bridges Project., 32(11): 1445-1451, 2017. 19) 17 6 : 814-817, 2017. 20) 5. 3) 38 S137- S146 2017 21) 46(4): 437-442, 2017 22) 15(1): 49-57, 2017. 23) 20(9): 975-982, 2017. 24) 81(9): 730-736, 2017. 25) No.39 2 - -, 85-89, 2017. 26) No.39 2 - - 90-94 2017. 27) Locomotive Pain Frontier 6(2): 46-47, 21017 28) 32(11): 1403-1404, 2017. 29) - - 32(11): 1405-1412, 2017. 30) 32(11) : 1483-1491, 2017. 31) 19 1 : 31-34 2017. 32) 119(12) 911-917 2017. 33),,, - 37 -
30 53-61 2017. 34) Hamamura T, Suganuma S, Takano A, Matsumoto T, Shimoyama H: The Efficacy of a Web-Based Screening and Brief Intervention for Reducing Alcohol Consumption Among Japanese Problem Drinkers: Protocol for a Single-Blind Randomized Controlled Trial. JMIR Res. Protoc. 2018;7(5):e10650) doi:10.2196/ 10650 35) Tanibuchi Y, Matsumoto T, Funada D, Shimane T: The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan. Neuropsychopharmacol Rep. 2018 Oct 19. doi: 10.1002/npr2.12035. 36) 53(2) 83-94 2018. 37) 5385) 212-225 2018. 38) 23(2) 121-129 2018. 39) 33(4) 435-440 2018. 40) 1(2) 12-15 2018. 41) 2012 2014 120(5): 361-368 2018. 42) 38(8) 844-846 2018. 43) 47(7) 799-804 2018. 44) 33(8) 959-964 2018. 45) Pros and Cons: Cons 60(9) 1019-1023 2018. 46) 59(3) 278-282 2018. 47) 202 40-46 2018. 48) Voice Bridge Project 20(1) 39-41 2018. 49) - - 33(6) 463-468 2018. 50) 39(12) 1570-1578 2018. 51) - 38 -
53(5) 151-170 2018. 52) Hiroko Kotajima-Murakami, Ayumi Takano, Yasukazu Ogai, Shotaro Tsukamoto, Maki Murakami, Daisuke Funada, Yuko Tanibuchi, Hisateru Tachimori, Kazushi Maruo, Tsuyoshi Sasaki, Toshihiko Matsumoto, Kazutaka Ikeda. Study of effects of ifenprodil in patients with methamphetamine dependence: protocol for an exploratory, randomized, double-blind, placebocontrolled trial. Neuropsychopharmacol Rep. 2019 (in press). 2. 1) : 15 2016.5.20 2) : 100 2016.6.17 3) : 38 2016.9.10 4) : SMARPP 51 2016.10.8 5) :? 51 2016.10.8 6) : SMARPP 51 2016.10.8 7) : SMARPP 7 2016.10.30 8) : SMARPP 34 2016.11.4 9) : 23 2016.11.27 10) : 51 2016.10.8 11) : 51 2016.10.8 12) : 2016.10.7 13) 2 23 2017.6.17 14) 35 113 2017.6.23-39 -
15) 64 113 2017.6.24 16) 5 51 2017.7.21. 17) 3 2017.8.6. 18) 8 Voice Bridges Project 29 2017.9.9. 19) 9 29 2017.9.9. 20) 2 2017.9.1. 21) 1 2017.9.24. 22) 7 58, 2017.10.6. 23) - 31 2017.11.24. 24) Takano A, Miyamoto Y, Matsumoto T, Kawakami N Satisfaction and Usability of a Web-Based Relapse Prevention Program for Japanese Drug Users the 21st East Asian Forum of Nursing Scholars & 11th International Nursing Conference Korea 2018.1.11-12. 25) Voice Bridges Project 37 2018.3.1-2. 26) 37 2018.3.2. 27) Yuko Tanibuchi, Toshihiko Matsumoto, Daisuke Funada, Yasunari Kawasoe, Satoshi Sakakibara, Nobuya Naruse, Shunichiro Ikeda, Takashi Sunami, Takeo Muto, Tetsuji Cho A study on factors of better treatment outcome for patients with new psychoactivesubstances-related disorders in specialized clinics or wards for drug dependence in Japan The College on Problems of Drug dependence 80th Annual Scientific Meeting, San Diego, 2018.6.9-14. 28) 33 Voice Bridges Project 114 2018.6.21. 29) 114 2018.6.21. 30) 33 114 2018.6.21. - 40 -
31) Voice Bridges Project 114 2018.6.22. 32) 114 2018.6.22. 33) Voice Bridges Project 30 2018.9.10. 34) 30 2018.9.10. 35) TC 30 2018.9.10. 36) Ayumi Takano, Yousuke Kumakura, Eriko Ban, Takashi Usami, Toshihiko Matsumoto : Cohort study and development of community-based support for drug users on probation in Japan, Voice Bridges Project. The 19th Congress of the International Society for Biomedical Research on Alcoholism, Kyoto, 2018.9.9-13. 37) Ayumi Takano, Sachiko Ono, Hayato Yamana, Hiroki Matsui, Toshihiko Matsumoto, Hideo Yasunaga, Norito Kawakami : Risk factors for long-term prescription of benzodiazepine: cohort study using a large health insurance claim database in Japan. The 19th Congress of the International Society for Biomedical Research on Alcoholism, Kyoto, 2018.9.9-13. 38) Ayumi Takano, Mitsuo Sase, Toshihiko Matsumoto, Norito Kawakami : Smartphone-based self-monitoring application for drug users: co-production with targeted users. The 19th Congress of the International Society for Biomedical Research on Alcoholism, Kyoto, 2018.9.9-13. 39) 26 2018.10.11 40) Voice Bridges Project 30 2018.9.9. 41) 41 2018.10.5. 42) 32 2018.10.23. 43) 65 2018.10.25. 44) 44 2018.10.28. - 41 -
45) 35 2018.12.1. 46) HIV 32 2018.12.4. 47) 1 25 2018.12.8. 1. http://www.moj.go.jp/content/001164749. pdf 2, (2016). https://www.ncnp.go.jp/nimh/yakubutsu/re port/pdf/j_nmhs_2016.pdf 3,, 2015 DAST-20 50: 310-324. - 42 -
/ 209/273 76.6% / 164/209 78.5% - 43 -
- 44 -
- 45 -
- 46 -
- 47 -
- 48 -
- 49 -
- 50 -
- 51 -
- 52 -
- 53 -
- 54 -
- 55 -
- 56 -
3 N=135 540 95% 377.7-702.3 1 1-57 -